2022 Q3 Form 10-Q Financial Statement

#000095017022013434 Filed on July 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.128M $3.414M $3.704M
YoY Change -1.97% -6.03% 4.04%
% of Gross Profit
Research & Development $10.49M $13.71M $13.24M
YoY Change 7.65% 58.74% 32.48%
% of Gross Profit
Depreciation & Amortization $6.000K $7.000K $8.000K
YoY Change -25.0% 250.0% 300.0%
% of Gross Profit
Operating Expenses $13.62M $17.12M $16.94M
YoY Change 5.28% 39.56% 24.99%
Operating Profit -$13.62M -$17.12M -$16.94M
YoY Change 5.28% 39.56% 24.99%
Interest Expense -$108.0K $234.0K $1.000K
YoY Change -144.44% -788.24% -99.52%
% of Operating Profit
Other Income/Expense, Net -$108.0K $234.0K $1.000K
YoY Change -144.44% -788.24% -99.52%
Pretax Income -$13.73M -$16.89M -$16.94M
YoY Change 8.14% 37.27% 26.88%
Income Tax
% Of Pretax Income
Net Earnings -$13.73M -$16.89M -$16.94M
YoY Change 8.14% 37.27% 26.92%
Net Earnings / Revenue
Basic Earnings Per Share -$0.54 -$0.67 -$0.67
Diluted Earnings Per Share -$0.54 -$668.3K -$670.5K
COMMON SHARES
Basic Shares Outstanding 25.40M 25.26M 25.26M
Diluted Shares Outstanding 25.49M 25.27M 25.26M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $69.08M $79.03M $93.60M
YoY Change -32.37% -22.38% -15.17%
Cash & Equivalents $28.34M $29.80M $45.39M
Short-Term Investments $40.75M $49.23M $48.21M
Other Short-Term Assets $291.0K $962.0K $1.479M
YoY Change -20.27% 5.6% -7.56%
Inventory
Prepaid Expenses
Receivables $732.0K $1.068M $785.0K
Other Receivables $1.092M $1.146M $1.170M
Total Short-Term Assets $71.20M $82.20M $97.00M
YoY Change -33.46% -23.68% -17.02%
LONG-TERM ASSETS
Property, Plant & Equipment $338.0K $205.0K $238.0K
YoY Change 57.94% 16.48% -76.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.829M $6.888M $8.160M
YoY Change -73.21% -80.79% -78.86%
Other Assets $2.807M $3.009M $2.798M
YoY Change 105.79% 167.23% 150.72%
Total Long-Term Assets $10.83M $10.66M $11.93M
YoY Change -62.51% -72.76% -71.46%
TOTAL ASSETS
Total Short-Term Assets $71.20M $82.20M $97.00M
Total Long-Term Assets $10.83M $10.66M $11.93M
Total Assets $82.03M $92.86M $108.9M
YoY Change -39.63% -36.75% -31.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.907M $2.815M $3.215M
YoY Change -3.74% 77.6% 78.61%
Accrued Expenses $6.951M $4.673M $3.999M
YoY Change 84.77% 47.41% 6.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.900M $7.500M $7.200M
YoY Change 56.14% 56.25% 30.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $440.0K $305.0K $402.0K
YoY Change -13.89% -51.97% -19.6%
Total Long-Term Liabilities $440.0K $305.0K $402.0K
YoY Change -13.89% -51.97% -19.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.900M $7.500M $7.200M
Total Long-Term Liabilities $440.0K $305.0K $402.0K
Total Liabilities $9.298M $7.793M $7.616M
YoY Change 48.67% 44.58% 24.85%
SHAREHOLDERS EQUITY
Retained Earnings -$203.7M -$189.9M -$173.1M
YoY Change 42.75% 46.08%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $72.73M $85.07M $101.3M
YoY Change
Total Liabilities & Shareholders Equity $82.03M $92.86M $108.9M
YoY Change -39.63% -36.75% -31.36%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$13.73M -$16.89M -$16.94M
YoY Change 8.14% 37.27% 26.92%
Depreciation, Depletion And Amortization $6.000K $7.000K $8.000K
YoY Change -25.0% 250.0% 300.0%
Cash From Operating Activities -$9.847M -$14.84M -$6.797M
YoY Change 7.51% 32.86% -51.97%
INVESTING ACTIVITIES
Capital Expenditures -$138.0K $26.00K $43.00K
YoY Change 193.62% -123.64% -33.85%
Acquisitions
YoY Change
Other Investing Activities $8.450M -$77.00K -$10.16M
YoY Change 19.11% -101.47% -86.37%
Cash From Investing Activities $8.312M -$51.00K -$10.21M
YoY Change 17.95% -101.0% -86.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 424.0K 18.00K
YoY Change
NET CHANGE
Cash From Operating Activities -9.847M -14.84M -6.797M
Cash From Investing Activities 8.312M -51.00K -10.21M
Cash From Financing Activities 424.0K 18.00K
Net Change In Cash -1.111M -14.87M -17.00M
YoY Change -47.4% 145.96% -80.85%
FREE CASH FLOW
Cash From Operating Activities -$9.847M -$14.84M -$6.797M
Capital Expenditures -$138.0K $26.00K $43.00K
Free Cash Flow -$9.709M -$14.87M -$6.840M
YoY Change 6.55% 34.41% -51.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25342138
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001800315
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity File Number
EntityFileNumber
001-39655
dei Entity Registrant Name
EntityRegistrantName
GALECTO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1957007
dei Entity Address Address Line1
EntityAddressAddressLine1
75 State Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02109
dei City Area Code
CityAreaCode
+45
dei Local Phone Number
LocalPhoneNumber
70 70 52 10
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-261000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-360000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-57000
us-gaap Net Income Loss
NetIncomeLoss
-25647000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13334
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.10
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
dei Trading Symbol
TradingSymbol
GLTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25395697
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29795000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62563000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
49231000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
37628000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3176000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9911000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
82202000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
110102000
CY2022Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
6888000
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
9048000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
554000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
834000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
205000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3009000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2028000
CY2022Q2 us-gaap Assets
Assets
92858000
CY2021Q4 us-gaap Assets
Assets
122215000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2815000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1531000
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4673000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3013000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7488000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4544000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
305000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
448000
CY2022Q2 us-gaap Liabilities
Liabilities
7793000
CY2021Q4 us-gaap Liabilities
Liabilities
4992000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.02
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25342138
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25261832
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25261832
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
276501000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
273655000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189937000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156112000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1499000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-320000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
85065000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117223000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92858000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122215000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13707000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8635000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26942000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18625000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3414000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3633000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7118000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7195000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
17121000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
12268000
us-gaap Operating Expenses
OperatingExpenses
34060000
us-gaap Operating Expenses
OperatingExpenses
25820000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17121000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12268000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34060000
us-gaap Operating Income Loss
OperatingIncomeLoss
-25820000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
156000
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
217000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
91000
CY2022Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-70000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-70000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
148000
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-86000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
88000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
82000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
234000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
235000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
173000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-16887000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-12302000
us-gaap Net Income Loss
NetIncomeLoss
-33825000
us-gaap Net Income Loss
NetIncomeLoss
-25647000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1179000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-428000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2018000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000
CY2022Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17691000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12126000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-889000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.34
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35004000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26075000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-371000
CY2022Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25270314
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25266096
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-719000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-889000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-371000
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-155000
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
23000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-360000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-57000
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-804000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
176000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
101314000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1419000
CY2022Q2 glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-719000
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-155000
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-16887000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
85065000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
152571000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
987000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
153000
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
23000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-12302000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
141432000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117223000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2823000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
us-gaap Net Income Loss
NetIncomeLoss
-33825000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
85065000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
165489000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
376000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
42000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
us-gaap Profit Loss
ProfitLoss
-25600000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-226000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
141432000
us-gaap Profit Loss
ProfitLoss
-33825000
us-gaap Profit Loss
ProfitLoss
-25647000
us-gaap Depreciation
Depreciation
15000
us-gaap Depreciation
Depreciation
5000
us-gaap Share Based Compensation
ShareBasedCompensation
2823000
us-gaap Share Based Compensation
ShareBasedCompensation
2018000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-438000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-234000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-70000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
207000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
207000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
28000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
37000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6740000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
182000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
981000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
841000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1284000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1266000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1790000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21637000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25320000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
40656000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
81051000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30415000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11724000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
180000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10258000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69507000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-31877000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-94827000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-891000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-371000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62563000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163836000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29795000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68638000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189900000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-16900000
us-gaap Profit Loss
ProfitLoss
-33800000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
240000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-12300000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
223000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35000
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
77656000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
96302000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.900
CY2022Q2 us-gaap Investments And Cash
InvestmentsAndCash
85900000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
82200000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7500000
CY2021Q4 us-gaap Investments And Cash
InvestmentsAndCash
109200000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
110100000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4500000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
205000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203000
CY2022Q2 us-gaap Depreciation
Depreciation
7000
us-gaap Depreciation
Depreciation
15000
CY2021Q2 us-gaap Depreciation
Depreciation
2000
us-gaap Depreciation
Depreciation
5000
CY2021Q2 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
117000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
125000
us-gaap Operating Lease Cost
OperatingLeaseCost
243000
CY2022Q2 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1068000
CY2021Q4 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
5569000
CY2022Q2 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
774000
CY2021Q4 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
1682000
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
705000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1728000
CY2022Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
372000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
598000
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
257000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
334000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3176000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9911000
CY2022Q2 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
us-gaap Operating Lease Cost
OperatingLeaseCost
244000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
120000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
969000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3013000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5760144
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.44
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
142000
us-gaap Operating Lease Payments
OperatingLeasePayments
234000
us-gaap Operating Lease Payments
OperatingLeasePayments
261000
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
287000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
513000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
229000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
16000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1045000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
76000
CY2022Q2 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
2282000
CY2021Q4 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
1575000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1738000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
601000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
269000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
399000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
384000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
438000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4673000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3998728
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.51
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1357655
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1774750
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.01
glto Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
110313
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5456002
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.44
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y8M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2166299
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1419000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
987000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2823000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2018000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25266096
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.905
CY2022Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25270314
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-16887000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-12302000
us-gaap Net Income Loss
NetIncomeLoss
-33825000
us-gaap Net Income Loss
NetIncomeLoss
-25647000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
CY2022Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.34
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.02

Files In Submission

Name View Source Status
0000950170-22-013434-index-headers.html Edgar Link pending
0000950170-22-013434-index.html Edgar Link pending
0000950170-22-013434.txt Edgar Link pending
0000950170-22-013434-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
glto-20220630.htm Edgar Link pending
glto-20220630.xsd Edgar Link pending
glto-20220630_cal.xml Edgar Link unprocessable
glto-20220630_def.xml Edgar Link unprocessable
glto-20220630_htm.xml Edgar Link completed
glto-20220630_lab.xml Edgar Link unprocessable
glto-20220630_pre.xml Edgar Link unprocessable
glto-ex31_1.htm Edgar Link pending
glto-ex31_2.htm Edgar Link pending
glto-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending